{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:32:26Z","timestamp":1778185946429,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["MOST 107-2314-B-182A-056 -MY3"],"award-info":[{"award-number":["MOST 107-2314-B-182A-056 -MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study tested the optimal time point for left intra-carotid arterial (LICA) administration of circulatory-derived autologous endothelial progenitor cells (EPCs) for improving the outcome in rat after acute ischemic stroke (IS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      Adult male SD rats (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200970) were equally categorized into group 1 (sham-operated control), group 2 (IS), group 3 (IS+EPCs\/1.2\u2009\u00d7\u200910\n                      <jats:sup>6<\/jats:sup>\n                      cells\/by LICA administration 3\u2009h after IS), group 4 (IS+EPCs\/LICA administration post-day-3 IS), group 5 (IS+EPCs\/LICA administration post-day-7 IS), group 6 (IS+EPCs\/LICA administration post-day-14 IS), and group 7 (IS+EPCs\/LICA administration post-day-28 IS). The brain infarct volume (BIV) (at day 60\/MRI) was lowest in group 1, highest in group 2, and significantly progressively increased from groups 3 to 7, whereas among the IS animals, the neurological function was significantly preserved in groups 3 to 6 than in groups 2 and 7 post-day-60 IS (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). By day 60, the endothelial cell markers at protein and cellular levels and number of small vessels exhibited an opposite pattern of BIV among the groups (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The protein and cellular levels of inflammation, and protein levels of oxidative stress, autophagy, and apoptosis were highest in group 2, lowest in group 1, and progressively increased from groups 3 to 7 (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The angiogenesis biomarkers at protein and cellular levels were significantly progressively increased from groups 1 to 3, then significantly progressively decreased from groups 4 to 7 (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early EPC administration provided better benefits on improving functional\/image\/molecular-cellular outcomes after acute IS in rat.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01739-y","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T09:02:39Z","timestamp":1591347759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke\u2014evaluating the impact of therapeutic time points on prognostic outcomes"],"prefix":"10.1186","volume":"11","author":[{"given":"Kun-Chen","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Tan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Lin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ruei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheung-Fat","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6305-5717","authenticated-orcid":false,"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"1739_CR1","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/jama.283.11.1429","volume":"283","author":"HJ Barnett","year":"2000","unstructured":"Barnett HJ, Gunton RW, Eliasziw M, et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA. 2000;283:1429\u201336.","journal-title":"JAMA"},{"key":"1739_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJM199811123392002","volume":"339","author":"HJ Barnett","year":"1998","unstructured":"Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339:1415\u201325.","journal-title":"N Engl J Med"},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1056\/NEJMoa002994","volume":"345","author":"O Benavente","year":"2001","unstructured":"Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med. 2001;345:1084\u201390.","journal-title":"N Engl J Med"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/01.STR.22.6.711","volume":"22","author":"Committee. NS","year":"1991","unstructured":"Committee. NS. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711\u201320.","journal-title":"Stroke"},{"key":"1739_CR5","first-page":"355","volume-title":"Stroke: pathophysiology, diagnosis, and management","author":"J Mohr","year":"1998","unstructured":"Mohr J, Gautier JC, Pessin MS. Internal carotid artery disease. In: HJM B, Mohr JP, Stein BM, Yatsu FM, editors. Stroke: pathophysiology, diagnosis, and management. New York: Churchill-Livingstone; 1998. p. 355\u2013400."},{"key":"1739_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJM197702172960703","volume":"296","author":"MS Pessin","year":"1977","unstructured":"Pessin MS, Duncan GW, Mohr JP, et al. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med. 1977;296:358\u201362.","journal-title":"N Engl J Med"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/WNL.54.3.660","volume":"54","author":"D Inzitari","year":"2000","unstructured":"Inzitari D, Eliasziw M, Sharpe BL, et al. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology. 2000;54:660\u20136.","journal-title":"Neurology"},{"key":"1739_CR8","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1001\/jama.1991.03470230047029","volume":"266","author":"MR Mayberg","year":"1991","unstructured":"Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991;266:3289\u201394.","journal-title":"JAMA"},{"key":"1739_CR9","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1161\/01.STR.0000042207.16156.B9","volume":"33","author":"JD Spence","year":"2002","unstructured":"Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33:2916\u201322.","journal-title":"Stroke"},{"key":"1739_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341.","journal-title":"Stroke"},{"key":"1739_CR11","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","volume":"31","author":"ZM Chen","year":"2000","unstructured":"Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31:1240\u20139.","journal-title":"Stroke"},{"key":"1739_CR12","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/hs1101.098524","volume":"32","author":"AJ Grau","year":"2001","unstructured":"Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32:2559\u201366.","journal-title":"Stroke"},{"key":"1739_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/01.STR.27.10.1817","volume":"27","author":"KW Muir","year":"1996","unstructured":"Muir KW, Weir CJ, Murray GD, et al. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27:1817\u201320.","journal-title":"Stroke"},{"key":"1739_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000086802","volume":"20","author":"HK Yip","year":"2005","unstructured":"Yip HK, Liou CW, Chang HW, et al. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis. 2005;20:120\u20138.","journal-title":"Cerebrovasc Dis"},{"key":"1739_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/STROKEAHA.107.489401","volume":"39","author":"HK Yip","year":"2008","unstructured":"Yip HK, Chang LT, Chang WN, et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke. 2008;39:69\u201374.","journal-title":"Stroke"},{"key":"1739_CR16","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/cc10002","volume":"15","author":"HK Yip","year":"2011","unstructured":"Yip HK, Tsai TH, Lin HS, et al. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care. 2011;15:R40.","journal-title":"Crit Care"},{"key":"1739_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijcard.2015.03.137","volume":"201","author":"YL Chen","year":"2015","unstructured":"Chen YL, Tsai TH, Wallace CG, et al. Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats. Int J Cardiol. 2015;201:668\u201383.","journal-title":"Int J Cardiol"},{"key":"1739_CR18","first-page":"2975","volume":"10","author":"PH Sung","year":"2018","unstructured":"Sung PH, Lin HS, Lin WC, et al. Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability. Am J Transl Res. 2018;10:2975\u201389.","journal-title":"Am J Transl Res"},{"key":"1739_CR19","doi-asserted-by":"publisher","first-page":"74537","DOI":"10.18632\/oncotarget.12902","volume":"7","author":"KH Chen","year":"2016","unstructured":"Chen KH, Chen CH, Wallace CG, et al. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget. 2016;7:74537\u201356.","journal-title":"Oncotarget"},{"key":"1739_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.brainres.2011.01.041","volume":"1381","author":"DC Wagner","year":"2011","unstructured":"Wagner DC, Riegelsberger UM, Michalk S, et al. Cleaved caspase-3 expression after experimental stroke exhibits different phenotypes and is predominantly non-apoptotic. Brain Res. 2011;1381:237\u201342.","journal-title":"Brain Res"},{"key":"1739_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3727\/096368911X589609","volume":"21","author":"J Boltze","year":"2012","unstructured":"Boltze J, Schmidt UR, Reich DM, et al. Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant. 2012;21:1199\u2013211.","journal-title":"Cell Transplant"},{"key":"1739_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/ehp536","volume":"31","author":"S Grajek","year":"2010","unstructured":"Grajek S, Popiel M, Gil L, et al. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J. 2010;31:691\u2013702.","journal-title":"Eur Heart J"},{"key":"1739_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ahj.2011.06.019","volume":"162","author":"JH Traverse","year":"2011","unstructured":"Traverse JH, Henry TD, Moye LA. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Am Heart J. 2011;162:671\u20137.","journal-title":"Am Heart J"},{"key":"1739_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijcard.2010.03.007","volume":"150","author":"S Leu","year":"2011","unstructured":"Leu S, Sun CK, Sheu JJ, et al. Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: an echocardiographic, six-month angiographic, and molecular-cellular study. Int J Cardiol. 2011;150:156\u201368.","journal-title":"Int J Cardiol"},{"key":"1739_CR25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/CCM.0b013e31819c0667","volume":"37","author":"CK Sun","year":"2009","unstructured":"Sun CK, Chang LT, Sheu JJ, et al. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med. 2009;37:1197\u2013205.","journal-title":"Crit Care Med"},{"key":"1739_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1253\/circj.72.1336","volume":"72","author":"HK Yip","year":"2008","unstructured":"Yip HK, Chang LT, Wu CJ, et al. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J. 2008;72:1336\u201345.","journal-title":"Circ J"},{"key":"1739_CR27","doi-asserted-by":"publisher","first-page":"108954","DOI":"10.1016\/j.biopha.2019.108954","volume":"116","author":"CC Yang","year":"2019","unstructured":"Yang CC, Chen YT, Chen CH, et al. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet. Biomed Pharmacother. 2019;116:108954.","journal-title":"Biomed Pharmacother"},{"key":"1739_CR28","doi-asserted-by":"publisher","first-page":"119227","DOI":"10.1016\/j.biomaterials.2019.119227","volume":"214","author":"HK Yip","year":"2019","unstructured":"Yip HK, Chen KH, Dubey NK, et al. Cerebro- and renoprotective activities through platelet-derived biomaterials against cerebrorenal syndrome in rat model. Biomaterials. 2019;214:119227.","journal-title":"Biomaterials"},{"key":"1739_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/jcbfm.2013.185","volume":"34","author":"G Weise","year":"2014","unstructured":"Weise G, Lorenz M, Posel C, et al. Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2014;34:e1\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1739_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2040-7378-4-17","volume":"4","author":"DC Wagner","year":"2012","unstructured":"Wagner DC, Bojko M, Peters M, et al. Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke. Exp Transl Stroke Med. 2012;4:17.","journal-title":"Exp Transl Stroke Med"},{"key":"1739_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.25493","volume":"86","author":"LL Cui","year":"2019","unstructured":"Cui LL, Golubczyk D, Tolppanen AM, et al. Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Ann Neurol. 2019;86:5\u201316.","journal-title":"Ann Neurol"},{"key":"1739_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbr.2017.07.039","volume":"352","author":"MG Balkaya","year":"2018","unstructured":"Balkaya MG, Trueman RC, Boltze J, et al. Behavioral outcome measures to improve experimental stroke research. Behav Brain Res. 2018;352:161\u201371.","journal-title":"Behav Brain Res"},{"key":"1739_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt544","volume":"6","author":"LL Cui","year":"2015","unstructured":"Cui LL, Kerkela E, Bakreen A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6:11.","journal-title":"Stem Cell Res Ther"},{"key":"1739_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1172\/JCI200420622","volume":"114","author":"A Taguchi","year":"2004","unstructured":"Taguchi A, Soma T, Tanaka H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114:330\u20138.","journal-title":"J Clin Invest"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01739-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:05:10Z","timestamp":1696190710000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01739-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01739-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23279\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23279\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23279\/v3","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were approved by the Institutional Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use Protocol No. 2017110201) and performed in accordance with the Guide for the Care and Use of Laboratory Animals, 8th edition (NIH publication No. 85-23, National Academy Press, Washington, DC, USA, revised 2011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}